Macrophage polarization and HIV-1 infection

Journal of Leukocyte Biology

Volumn 87, Issue 4, 2010, Pages 599-608

  Cassol, Edana ^a,b,c   Cassetta, Luca ^a   Alfano, Massimo ^a   Poli, Guido ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Chemokines; Cytokines; DC SIGN; HIV 1; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; LECTIN;

CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL POLARITY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFECTION SENSITIVITY; INTERFERON PRODUCTION; LYMPHOID TISSUE; MACROPHAGE; MIXED INFECTION; MONOCYTE; MUCOSA; NONHUMAN; PATHOGENESIS; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TH1 CELL; TISSUE INJURY; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERONS; MACROPHAGE ACTIVATION; MACROPHAGES; MUCOUS MEMBRANE; TH1 CELLS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77950587926     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1009673     Document Type: Review

References (162)

1. Zhu, J., Paul, W. E. (2008) CD4 T cells: fates, functions, and faults. Blood 112, 1557-1569.
2. Urban Jr., J. F., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., Finkelman, F. D. (1998) IL-13, IL-4Rα, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8, 255-264. (Pubitemid 28123752)
3. Lawn, S. D., Butera, S. T., Folks, T. M. (2001) Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 14, 753-777. (Pubitemid 32979630)
4. Balagopal, A., Philp, F. H., Astemborski, J., Block, T. M., Mehta, A., Long, R., Kirk, G. D., Mehta, S. H., Cox, A. L., Thomas, D. L., Ray, S. C. (2008) Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 135, 226-233. (Pubitemid 351899010)
5. Ancuta, P., Kamat, A., Kunstman, K. J., Kim, E. Y., Autissier, P., Wurcel, A., Zaman, T., Stone, D., Mefford, M., Morgello, S., Singer, E. J., Wolinsky, S. M., Gabuzda, D. (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3, e2516.
6. Sodora, D. L., Allan, J. S., Apetrei, C., Brenchley, J. M., Douek, D. C., Else, J. G., Estes, J. D., Hahn, B. H., Hirsch, V. M., Kaur, A., Kirchhoff, F., Muller-Trutwin, M., Pandrea, I., Schmitz, J. E., Silvestri, G. (2009) Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat. Med. 15, 861-865.
7. Paiardini, M., Pandrea, I., Apetrei, C., Silvestri, G. (2009) Lessons learned from the natural hosts of HIV-related viruses. Annu. Rev. Med. 60, 485-495.
8. Appay, V., Sauce, D. (2008) Immune activation and inflammation in HIV-1 infection: causes and consequences. J. Pathol. 214, 231-241. (Pubitemid 351160160)
9. Hoffmann, K. F., Cheever, A. W., Wynn, T. A. (2000) IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164, 6406-6416.
10. Gazzinelli, R. T., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kuhn, R., Muller, W., Trinchieri, G., Sher, A. (1996) In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 157, 798-805. (Pubitemid 26231385)
11. Baenziger, S., Heikenwalder, M., Johansen, P., Schlaepfer, E., Hofer, U., Miller, R. C., Diemand, S., Honda, K., Kundig, T. M., Aguzzi, A., Speck, R. F. (2009) Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 113, 377-388.
12. Mosmann, T. R., Sad, S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146.
13. Weaver, C. T., Hatton, R. D., Mangan, P. R., Harrington, L. E. (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821-852.
14. Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P., Reed, S. G., Morris, S. L., Roederer, M., Seder, R. A. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13, 843-850. (Pubitemid 47038186)
15. Sutton, C., Brereton, C., Keogh, B., Mills, K. H., Lavelle, E. C. (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691. (Pubitemid 44036274)
16. Wynn, T. A. (2003) IL-13 effector functions. Annu. Rev. Immunol. 21, 425-456.
17. Cassol, E., Cassetta, L., Rizzi, C., Alfano, M., Poli, G. (2009) M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J. Immunol. 182, 6237-6246.
18. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
19. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686. (Pubitemid 39457982)
20. Stout, R. D., Suttles, J. (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76, 509-513.
21. Grage-Griebenow, E., Flad, H. D., Ernst, M. (2001) Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69, 11-20. (Pubitemid 32095112)
22. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
23. Bach, E. A., Aguet, M., Schreiber, R. D. (1997) The IFN γ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15, 563-591. (Pubitemid 27169292)
24. Bonecchi, R., Sozzani, S., Stine, J. T., Luini, W., D'Amico, G., Allavena, P., Chantry, D., Mantovani, A. (1998) Divergent effects of interleukin-4 and interferon-γ on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 92, 2668-2671. (Pubitemid 28469077)
25. Martinez-Pomares, L., Hanitsch, L. G., Stillion, R., Keshav, S., Gordon, S. (2005) Expression of mannose receptor and ligands for its cysteine-rich domain in venous sinuses of human spleen. Lab. Invest. 85, 1238-1249. (Pubitemid 41348639)
26. De Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G., de Vries, J. E. (1993) Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151, 6370-6381. (Pubitemid 23340383)
27. Trofimov, S., Pantsulaia, I., Kobyliansky, E., Livshits, G. (2004) Circulating levels of receptor activator of nuclear factor-κB ligand/osteoprotegerin/macrophage-colony stimulating factor in a presumably healthy human population. Eur. J. Endocrinol. 150, 305-311. (Pubitemid 38443780)
28. Martinez, F. O., Gordon, S., Locati, M., Mantovani, A. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311. (Pubitemid 44715100)
29. Auffray, C., Sieweke, M. H., Geissmann, F. (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692.
30. Passlick, B., Flieger, D., Ziegler-Heitbrock, H. W. (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534. (Pubitemid 19286475)
31. Grage-Griebenow, E., Flad, H. D., Ernst, M., Bzowska, M., Skrzeczynska, J., Pryjma, J. (2000) Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. Immunobiology 202, 42-50. (Pubitemid 30323615)
32. Ziegler-Heitbrock, H. W. (2000) Definition of human blood monocytes. J. Leukoc. Biol. 67, 603-606.
33. Hume, D. A. (2006) The mononuclear phagocyte system. Curr. Opin. Immunol. 18, 49-53.
34. Fox, S. W., Fuller, K., Bayley, K. E., Lean, J. M., Chambers, T. J. (2000) TGF-β 1 and IFN-γ direct macrophage activation by TNF-α to osteoclastic or cytocidal phenotype. J. Immunol. 165, 4957-4963.
35. Chambers, T. J. (2000) Regulation of the differentiation and function of osteoclasts. J. Pathol. 192, 4-13.
36. Schenk, M., Mueller, C. (2007) Adaptations of intestinal macrophages to an antigen-rich environment. Semin. Immunol. 19, 84-93. (Pubitemid 46810284)
37. Smythies, L. E., Sellers, M., Clements, R. H., Mosteller-Barnum, M., Meng, G., Benjamin, W. H., Orenstein, J. M., Smith, P. D. (2005) Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115, 66-75. (Pubitemid 40385506)
38. Smith, P. D., Ochsenbauer-Jambor, C., Smythies, L. E. (2005) Intestinal macrophages: unique effector cells of the innate immune system. Immunol. Rev. 206, 149-159. (Pubitemid 41105168)
39. Lassmann, H., Schmied, M., Vass, K., Hickey, W. F. (1993) Bone marrow derived elements and resident microglia in brain inflammation. Glia 7, 19-24.
40. Tarling, J. D., Lin, H. S., Hsu, S. (1987) Self-renewal of pulmonary alveolar macrophages: evidence from radiation chimera studies. J. Leukoc. Biol. 42, 443-446.
41. Rauh, M. J., Ho, V., Pereira, C., Sham, A., Sly, L. M., Lam, V., Huxham, L., Minchinton, A. I., Mui, A., Krystal, G. (2005) SHIP represses the generation of alternatively activated macrophages. Immunity 23, 361-374. (Pubitemid 41443438)
42. Xiao, W., Hong, H., Kawakami, Y., Lowell, C. A., Kawakami, T. (2008) Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5. J. Clin. Invest. 118, 924-934. (Pubitemid 351364600)
43. Ishii, M., Wen, H., Corsa, C.A., Liu, T., Coelho, A.L., Allen, R.M., Carson IV, W. F., Cavassani, K. A., Li, X., Lukacs, N. W., Hogaboam, C. M., Dou, Y., Kunkel, S. L. (2009) Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114, 3244-3254.
44. De Santa, F., Totaro, M. G., Prosperini, E., Notarbartolo, S., Testa, G., Natoli, G. (2007) The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130, 1083-1094. (Pubitemid 47410272)
45. Mantovani, A., Locati, M. (2009) Orchestration of macrophage polarization. Blood 114, 3135-3136.
46. Porcheray, F., Viaud, S., Rimaniol, A. C., Leone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D., Gras, G. (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481-489. (Pubitemid 41719844)
47. Martinez, F. O., Helming, L., Gordon, S. (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483.
48. Sinistro, A., Ciaprini, C., Natoli, S., Sussarello, E., Carducci, F. C., Almerighi, C., Capozzi, M., Bolacchi, F., Rocchi, G., Bergamini, A. (2007) Lipopolysaccharide desensitizes monocytes-macrophages to CD40 ligand stimulation. Immunology 122, 362-370. (Pubitemid 47556473)
49. Medvedev, A. E., Piao, W., Shoenfelt, J., Rhee, S. H., Chen, H., Basu, S., Wahl, L. M., Fenton, M. J., Vogel, S. N. (2007) Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J. Biol. Chem. 282, 16042-16053. (Pubitemid 47100380)
50. Medvedev, A. E., Sabroe, I., Hasday, J. D., Vogel, S. N. (2006) Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J. Endotoxin Res. 12, 133-150. (Pubitemid 47487520)
51. Mantovani, A., Sica, A., Locati, M. (2005) Macrophage polarization comes of age. Immunity 23, 344-346.
52. Goerdt, S., Politz, O., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., Hakiy, N., Klemke, C. D., Dippel, E., Kodelja, V., Orfanos, C. E. (1999) Alternative versus classical activation of macrophages. Pathobiology 67, 222-226. (Pubitemid 30135909)
53. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., Hill, A. M. (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173.
54. Soilleux, E. J., Morris, L. S., Leslie, G., Chehimi, J., Luo, Q., Levroney, E., Trowsdale, J., Montaner, L. J., Doms, R. W., Weissman, D., Coleman, N., Lee, B. (2002) Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71, 445-457.
55. Gurney, K. B., Elliott, J., Nassanian, H., Song, C., Soilleux, E., McGowan, I., Anton, P. A., Lee, B. (2005) Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa. J. Virol. 79, 5762-5773. (Pubitemid 40548245)
56. Christophi, G. P., Panos, M., Hudson, C. A., Christophi, R. L., Gruber, R. C., Mersich, A. T., Blystone, S. D., Jubelt, B., Massa, P. T. (2009) Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Lab. Invest. 89, 742-759.
57. Dheen, S. T., Kaur, C., Ling, E. A. (2007) Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 14, 1189-1197. (Pubitemid 46739320)
58. Behrens, E. M. (2008) Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell? Autoimmun. Rev. 7, 305-308.
59. Szekanecz, Z., Koch, A. E. (2007) Macrophages and their products in rheumatoid arthritis. Curr. Opin. Rheumatol. 19, 289-295. (Pubitemid 46597469)
60. Suarez, C. J., Parker, N. J., Finn, P. W. (2008) Innate immune mechanism in allergic asthma. Curr. Allergy Asthma Rep. 8, 451-459.
61. Burke, L. A., Wilkinson, J. R., Howell, C. J., Lee, T. H. (1991) Interactions of macrophages and monocytes with granulocytes in asthma. Eur. Respir. J. Suppl. 13, 85s-90s.
62. De Palma, M., Murdoch, C., Venneri, M. A., Naldini, L., Lewis, C. E. (2007) Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol. 28, 519-524. (Pubitemid 47437413)
63. Lewis, C. E., De Palma, M., Naldini, L. (2007) Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res. 67, 8429-8432. (Pubitemid 47437413)
64. Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., Mantovani, A. (2008) Macrophage polarization in tumor progression. Semin. Cancer Biol. 18, 349-355.
65. Mantovani, A., Sica, A., Allavena, P., Garlanda, C., Locati, M. (2009) Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum. Immunol. 70, 325-330.
66. Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., Colombo, M. P. (2005) Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65, 3437-3446. (Pubitemid 40524630)
67. Colombo, M. P., Mantovani, A. (2005) Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion. Cancer Res. 65, 9113-9116.
68. Abramson, S. L., Gallin, J. I. (1990) IL-4 inhibits superoxide production by human mononuclear phagocytes. J. Immunol. 144, 625-630.
69. Alfano, M., Crotti, A., Vicenzi, E., Poli, G. (2008) New players in cytokine control of HIV infection. Curr. HIV/AIDS Rep. 5, 27-32. (Pubitemid 351480778)
70. Herbein, G., Khan, K. A. (2008) Is HIV infection a TNF receptor signaling-driven disease? Trends Immunol. 29, 61-67.
71. Kedzierska, K., Crowe, S. M. (2001) Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12, 133-150. (Pubitemid 32963913)
72. Cassol, E., Alfano, M., Biswas, P., Poli, G. (2006) Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J. Leukoc. Biol. 80, 1018-1030. (Pubitemid 44646308)
73. Brown, J. N., Kohler, J. J., Coberley, C. R., Sleasman, J. W., Goodenow, M. M. (2008) HIV-1 activates macrophages independent of Toll-like receptors. PLoS One 3, e3664.
74. Chan, G., Bivins-Smith, E. R., Smith, M. S., Smith, P. M., Yurochko, A. D. (2008) Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J. Immunol. 181, 698-711.
75. Chan, G., Bivins-Smith, E. R., Smith, M. S., Yurochko, A. D. (2009) NF-κB and phosphatidylinositol 3-kinase activity mediates the HCMV-induced atypical M1/M2 polarization of monocytes. Virus Res. 144, 329-333.
76. Kukavica-Ibrulj, I., Hamelin, M. E., Prince, G. A., Gagnon, C., Bergeron, Y., Bergeron, M. G., Boivin, G. (2009) Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J. Virol. 83, 1341-1349.
77. Pribul, P. K., Harker, J., Wang, B., Wang, H., Tregoning, J. S., Schwarze, J., Openshaw, P. J. (2008) Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J. Virol. 82, 4441-4448. (Pubitemid 351563680)
78. Van Reeth, K., Adair, B. (1997) Macrophages and respiratory viruses. Pathol. Biol. (Paris) 45, 184-192.
79. Laza-Stanca, V., Stanciu, L. A., Message, S. D., Edwards, M. R., Gern, J. E., Johnston, S. L. (2006) Rhinovirus replication in human macrophages induces NF-κB-dependent tumor necrosis factor α production. J. Virol. 80, 8248-8258. (Pubitemid 44182324)
80. Berg, K., Andersen, H., Owen, T. C. (2004) The regulation of rhinovirus infection in vitro by IL-8, HuIFN-α, and TNF-α. APMIS 112, 172-182. (Pubitemid 38703622)
81. Oliver, B. G., Lim, S., Wark, P., Laza-Stanca, V., King, N., Black, J. L., Burgess, J. K., Roth, M., Johnston, S. L. (2008) Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 63, 519-525. (Pubitemid 351831162)
82. Maines, T. R., Szretter, K. J., Perrone, L., Belser, J. A., Bright, R. A., Zeng, H., Tumpey, T. M., Katz, J. M. (2008) Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol. Rev. 225, 68-84.
83. Frieman, M., Heise, M., Baric, R. (2008) SARS coronavirus and innate immunity. Virus Res. 133, 101-112.
84. Ryman, K. D., Klimstra, W. B. (2008) Host responses to αvirus infection. Immunol. Rev. 225, 27-45.
85. Carter, C. A., Ehrlich, L. S. (2008) Cell biology of HIV-1 infection of macrophages. Annu. Rev. Microbiol. 62, 425-443.
86. Morrow, G., Vachot, L., Vagenas, P., Robbiani, M. (2007) Current concepts of HIV transmission. Curr. HIV/AIDS Rep. 4, 29-35.
87. Wahl, S. M., Greenwell-Wild, T., Vazquez, N. (2006) HIV accomplices and adversaries in macrophage infection. J. Leukoc. Biol. 80, 973-983. (Pubitemid 44646303)
88. Kaul, M., Lipton, S. A. (2006) Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J. Neuroimmune Pharmacol. 1, 138-151. (Pubitemid 44257489)
89. Rock, R. B., Peterson, P. K. (2006) Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J. Neuroimmune Pharmacol. 1, 117-126. (Pubitemid 44257487)
90. Kaul, M., Lipton, S. A. (2006) Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 4, 307-318. (Pubitemid 44027720)
91. Orenstein, J. M., Fox, C., Wahl, S. M. (1997) Macrophages as a source of HIV during opportunistic infections. Science 276, 1857-1861. (Pubitemid 27443662)
92. Perno, C. F., Svicher, V., Schols, D., Pollicita, M., Balzarini, J., Aquaro, S. (2006) Therapeutic strategies towards HIV-1 infection in macrophages. Antiviral Res. 71, 293-300. (Pubitemid 44223775)
93. Alexaki, A., Liu, Y., Wigdahl, B. (2008) Cellular reservoirs of HIV-1 and their role in viral persistence. Curr. HIV Res. 6, 388-400.
94. Shehu-Xhilaga, M., Tachedjian, G., Crowe, S. M., Kedzierska, K. (2005) Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1. Curr. Med. Chem. 12, 1705-1719. (Pubitemid 40894996)
95. Geeraert, L., Kraus, G., Pomerantz, R. J. (2008) Hide-and-seek: the challenge of viral persistence in HIV-1 infection. Annu. Rev. Med. 59, 487-501. (Pubitemid 351287951)
96. Shen, L., Siliciano, R. F. (2008) Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J. Allergy Clin. Immunol. 122, 22-28. (Pubitemid 351899083)
97. Peterson, S., Reid, A. P., Kim, S., Siliciano, R. F. (2007) Treatment implications of the latent reservoir for HIV-1. Adv. Pharmacol. 55, 411-425.
98. Kedzierska, K., Ellery, P., Mak, J., Lewin, S. R., Crowe, S. M., Jaworowski, A. (2002) HIV-1 down-modulates γ signaling chain of Fc γ R in human macrophages: a possible mechanism for inhibition of phagocytosis. J. Immunol. 168, 2895-2903. (Pubitemid 34211669)
99. Musher, D. M., Watson, D. A., Nickeson, D., Gyorkey, F., Lahart, C., Rossen, R. D. (1990) The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am. J. Med. Sci. 299, 158-163. (Pubitemid 20085233)
100. Kedzierska, K., Crowe, S. M. (2002) The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr. Med. Chem. 9, 1893-1903. (Pubitemid 35230257)
101. Pittis, M. G., Prada, F., Mangano, A., Perez, L., Sternik, G., Redondo, J., Bologna, R., Sen, L. (1997) Monocyte phagolysosomal fusion in children born to human immunodeficiency virus-infected mothers. Pediatr. Infect. Dis. J. 16, 24-28. (Pubitemid 27063106)
102. Smith, P. D., Ohura, K., Masur, H., Lane, H. C., Fauci, A. S., Wahl, S. M. (1984) Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J. Clin. Invest. 74, 2121-2128. (Pubitemid 15197356)
103. Poli, G., Bottazzi, B., Acero, R., Bersani, L., Rossi, V., Introna, M., Lazzarin, A., Galli, M., Mantovani, A. (1985) Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. Clin. Exp. Immunol. 62, 136-142. (Pubitemid 15229739)
104. Mastroianni, C. M., Lichtner, M., Mengoni, F., D'Agostino, C., Forcina, G., d'Ettorre, G., Santopadre, P., Vullo, V. (1999) Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients. AIDS 13, 883-890.
105. Wahl, S. M., Allen, J. B., Gartner, S., Orenstein, J. M., Popovic, M., Chenoweth, D. E., Arthur, L. O., Farrar, W. L., Wahl, L. M. (1989) HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J. Immunol. 142, 3553-3559. (Pubitemid 19137488)
106. Herbein, G., Mahlknecht, U., Batliwalla, F., Gregersen, P., Pappas, T., Butler, J., O'Brien, W. A., Verdin, E. (1998) Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395, 189-194. (Pubitemid 28425660)
107. Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., Wolinsky, S. M., Detels, R. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179, 859-870. (Pubitemid 29159331)
108. Hazenberg, M. D., Otto, S. A., van Benthem, B. H., Roos, M. T., Coutinho, R. A., Lange, J. M., Hamann, D., Prins, M., Miedema, F. (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17, 1881-1888. (Pubitemid 37070273)
109. Deeks, S. G., Kitchen, C. M., Liu, L., Guo, H., Gascon, R., Narvaez, A. B., Hunt, P., Martin, J. N., Kahn, J. O., Levy, J., McGrath, M. S., Hecht, F. M. (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104, 942-947. (Pubitemid 39038012)
110. Brenchley, J. M., Price, D. A., Douek, D. C. (2006) HIV disease: fallout from a mucosal catastrophe? Nat. Immunol. 7, 235-239.
111. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B. R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J. N., Hecht, F. M., Picker, L. J., Lederman, M. M., Deeks, S. G., Douek, D. C. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371. (Pubitemid 44924494)
112. Douek, D. C., Picker, L. J., Koup, R. A. (2003) T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21, 265-304.
113. Porcheray, F., Samah, B., Leone, C., Dereuddre-Bosquet, N., Gras, G. (2006) Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. Virology 349, 112-120. (Pubitemid 43732479)
114. Swingler, S., Mann, A., Jacque, J., Brichacek, B., Sasseville, V. G., Williams, K., Lackner, A. A., Janoff, E. N., Wang, R., Fisher, D., Stevenson, M. (1999) HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5, 997-1103. (Pubitemid 29439569)
115. Shen, R., Richter, H. E., Clements, R. H., Novak, L., Huff, K., Bimczok, D., Sankaran-Walters, S., Dandekar, S., Clapham, P. R., Smythies, L. E., Smith, P. D. (2009) Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J. Virol. 83, 3258-3267.
116. Smith, P. D., Meng, G., Salazar-Gonzalez, J. F., Shaw, G. M. (2003) Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J. Leukoc. Biol. 74, 642-649. (Pubitemid 38040339)
117. Smith, P. D., Meng, G., Sellers, M. T., Rogers, T. S., Shaw, G. M. (2000) Biological parameters of HIV-1 infection in primary intestinal lymphocytes and macrophages. J. Leukoc. Biol. 68, 360-365.
118. Peng, G., Lei, K. J., Jin, W., Greenwell-Wild, T., Wahl, S. M. (2006) Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 203, 41-46.
119. Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., Haase, A. T. (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-362. (Pubitemid 23101311)
120. Martin, J. C., Bandres, J. C. (1999) Cells of the monocyte-macrophage lineage and pathogenesis of HIV-1 infection. J. Acquir. Immune Defic. Syndr. 22, 413-429. (Pubitemid 30027491)
121. Bowman, M. C., Archin, N. M., Margolis, D. M. (2009) Pharmaceutical approaches to eradication of persistent HIV infection. Expert Rev. Mol. Med. 11, e6.
122. Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., Pomerantz, R. J. (2009) The challenge of finding a cure for HIV infection. Science 323, 1304-1307.
123. Marsden, M. D., Zack, J. A. (2009) Eradication of HIV: current challenges and new directions. J. Antimicrob. Chemother. 63, 7-10.
124. Kim, W. K., Alvarez, X., Fisher, J., Bronfin, B., Westmoreland, S., McLaurin, J., Williams, K. (2006) CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am. J. Pathol. 168, 822-834. (Pubitemid 43327735)
125. Roberts, E. S., Masliah, E., Fox, H. S. (2004) CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J. Neuropathol. Exp. Neurol. 63, 1255-1264. (Pubitemid 39603397)
126. Fischer-Smith, T., Bell, C., Croul, S., Lewis, M., Rappaport, J. (2008) Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J. Neurovirol. 14, 318-326.
127. Yearley, J. H., Pearson, C., Shannon, R. P., Mansfield, K. G. (2007) Phenotypic variation in myocardial macrophage populations suggests a role for macrophage activation in SIV-associated cardiac disease. AIDS Res. Hum. Retroviruses 23, 515-524. (Pubitemid 46700884)
128. Thieblemont, N., Weiss, L., Sadeghi, H. M., Estcourt, C., Haeffner-Cavaillon, N. (1995) CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25, 3418-3424. (Pubitemid 26004949)
129. Pulliam, L., Gascon, R., Stubblebine, M., McGuire, D., McGrath, M. S. (1997) Unique monocyte subset in patients with AIDS dementia. Lancet 349, 692-695. (Pubitemid 27107748)
130. Jaworowski, A., Kamwendo, D. D., Ellery, P., Sonza, S., Mwapasa, V., Tadesse, E., Molyneux, M. E., Rogerson, S. J., Meshnick, S. R., Crowe, S. M. (2007) CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection. J. Infect. Dis. 196, 38-42. (Pubitemid 46982735)
131. Ellery, P. J., Tippett, E., Chiu, Y. L., Paukovics, G., Cameron, P. U., Solomon, A., Lewin, S. R., Gorry, P. R., Jaworowski, A., Greene, W. C., Sonza, S., Crowe, S. M. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178, 6581-6589. (Pubitemid 46717442)
132. Belge, K. U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T., Ziegler-Heitbrock, L. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168, 3536-3542.
133. Ancuta, P., Autissier, P., Wurcel, A., Zaman, T., Stone, D., Gabuzda, D. (2006) CD16+ monocyte-derived macrophages activate resting T cells for HIV infection by producing CCR3 and CCR4 ligands. J. Immunol. 176, 5760-5771.
134. Ancuta, P., Kunstman, K. J., Autissier, P., Zaman, T., Stone, D., Wolinsky, S. M., Gabuzda, D. (2006) CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344, 267-276. (Pubitemid 43049614)
135. Fischer-Smith, T., Tedaldi, E. M., Rappaport, J. (2008) CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS Res. Hum. Retroviruses 24, 417-421. (Pubitemid 351457747)
136. Baribaud, F., Doms, R. W., Pohlmann, S. (2002) The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination? Expert Opin. Ther. Targets 6, 423-431.
137. Feng, Z. H., Wang, Q. C., Nie, Q. H., Jia, Z. S., Zhou, Y. X. (2004) DC-SIGN: binding receptor for HCV? World J. Gastroenterol. 10, 925-929.
138. Han, D. P., Lohani, M., Cho, M. W. (2007) Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J. Virol. 81, 12029-12039. (Pubitemid 47623833)
139. Lozach, P. Y., Burleigh, L., Staropoli, I., Navarro-Sanchez, E., Harriague, J., Virelizier, J. L., Rey, F. A., Despres, P., Arenzana-Seisdedos, F., Amara, A. (2005) Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J. Biol. Chem. 280, 23698-23708. (Pubitemid 40884852)
140. Saidi, H., Carbonneil, C., Magri, G., Eslahpazire, J., Sekaly, R. P., Belec, L. (2010) Differential modulation of CCR5-tropic human immunodeficiency virus-1 transfer from macrophages towards T cells under interleukin-4/ interleukin-13 microenvironment. Hum. Immunol. 71, 1-13.
141. De Witte, L., Nabatov, A., Geijtenbeek, T. B. (2008) Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol. Med. 14, 12-19.
142. Requena, M., Bouhlal, H., Nasreddine, N., Saidi, H., Gody, J. C., Aubry, S., Gresenguet, G., Kazatchkine, M. D., Sekaly, R. P., Belec, L., Hocini, H. (2008) Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins. Immunology 123, 508-518. (Pubitemid 351280964)
143. Arrighi, J. F., Pion, M., Garcia, E., Escola, J. M., van Kooyk, Y., Geijtenbeek, T. B., Piguet, V. (2004) DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200, 1279-1288. (Pubitemid 39552569)
144. Pepper, D. J., Rebe, K., Morroni, C., Wilkinson, R. J., Meintjes, G. (2009) Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses. PLoS One 4, e4520.
145. Harries, A. D. (1990) Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 335, 387-390. (Pubitemid 20059358)
146. Borkow, G., Bentwich, Z. (2006) HIV and helminth co-infection: is deworming necessary? Parasite Immunol. 28, 605-612. (Pubitemid 44581386)
147. Idemyor, V. (2007) Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two Titans. HIV Clin. Trials 8, 246-253.
148. Benoit, M., Desnues, B., Mege, J. L. (2008) Macrophage polarization in bacterial infections. J. Immunol. 181, 3733-3739.
149. Ehrt, S., Schnappinger, D., Bekiranov, S., Drenkow, J., Shi, S., Gingeras, T. R., Gaasterland, T., Schoolnik, G., Nathan, C. (2001) Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194, 1123-1140. (Pubitemid 32995782)
150. O'Reilly, M., Newcomb, D. E., Remick, D. (1999) Endotoxin, sepsis, and the primrose path. Shock 12, 411-420.
151. Schreiber, T., Ehlers, S., Heitmann, L., Rausch, A., Mages, J., Murray, P. J., Lang, R., Holscher, C. (2009) Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J. Immunol. 183, 1301-1312.
152. Almeida, A. S., Lago, P. M., Boechat, N., Huard, R. C., Lazzarini, L. C., Santos, A. R., Nociari, M., Zhu, H., Perez-Sweeney, B. M., Bang, H., Ni, Q., Huang, J., Gibson, A. L., Flores, V. C., Pecanha, L. R., Kritski, A. L., Lapa e Silva, J. R., Ho, J. L. (2009) Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J. Immunol. 183, 718-731.
153. Raju, B., Hoshino, Y., Belitskaya-Levy, I., Dawson, R., Ress, S., Gold, J. A., Condos, R., Pine, R., Brown, S., Nolan, A., Rom, W. N., Weiden, M. D. (2008) Gene expression profiles of bronchoalveolar cells in pulmonary TB. Tuberculosis (Edinb.) 88, 39-51. (Pubitemid 350267356)
154. Mylonas, K. J., Nair, M. G., Prieto-Lafuente, L., Paape, D., Allen, J. E. (2009) Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing. J. Immunol. 182, 3084-3094.
155. Siracusa, M. C., Reece, J. J., Urban Jr., J. F., Scott, A. L. (2008) Dynamics of lung macrophage activation in response to helminth infection. J. Leukoc. Biol. 84, 1422-1433.
156. Donnelly, S., Stack, C. M., O'Neill, S. M., Sayed, A. A., Williams, D. L., Dalton, J. P. (2008) Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J. 22, 4022-4032.
157. Modjarrad, K. (2009) Which helminth coinfections really affect HIV disease progression? AIDS 23, 276-277, author reply 277-278.
158. Walson, J. L., Herrin, B. R., John-Stewart, G. (2009) Deworming helminth co-infected individuals for delaying HIV disease progression. Cochrane Database Syst. Rev. CD006419.
159. Hewitson, J. P., Grainger, J. R., Maizels, R. M. (2009) Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol. Biochem. Parasitol. 167, 1-11.
160. Hopkin, J. (2009) Immune and genetic aspects of asthma, allergy and parasitic worm infections: evolutionary links. Parasite Immunol. 31, 267-273.
161. Bentwich, Z. (2003) Concurrent infections that rise the HIV viral load. J. HIV Ther. 8, 72-75.
162. Modjarrad, K., Zulu, I., Redden, D. T., Njobvu, L., Lane, H. C., Bentwich, Z., Vermund, S. H. (2005) Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J. Infect. Dis. 192, 1277-1283. (Pubitemid 41368430)